Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    today
    Change Detected
    Summary
    Important update:The recent change on the webpage regarding the value "Cookie Preferences" represents an update to the privacy settings options available to users. Users can now choose between customizing their privacy settings or accepting all cookies, indicating a shift in how the website manages user data and privacy preferences.
    Difference
    45%
    Check dated 2024-03-01T01:33:12.000Z thumbnail image
  2. Check
    yesterday
    Change Detected
    Summary
    Important update:The recent change on the webpage now prompts users to manage their privacy settings by choosing between customizing their preferences or accepting all cookies, emphasizing the importance of privacy choices. This update likely pertains to the website's Cookie Preferences section, indicating a shift towards enhancing user privacy and data protection.
    Difference
    30%
    Check dated 2024-02-29T00:46:12.000Z thumbnail image
  3. Check
    2 days ago
    Change Detected
    Summary
    Important update:The value on the webpage has changed from "Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as Neoadjuvant Treatment" to "Merck to Participate in the TD Cowen 44th Annual Health Care Conference." This change represents a shift from a positive regulatory opinion announcement to an upcoming participation in a healthcare conference, indicating a potential shift in focus or upcoming developments for Merck.
    Difference
    48%
    Check dated 2024-02-27T23:34:12.000Z thumbnail image
  4. Check
    3 days ago
    Change Detected
    Summary
    Important update:The recent change on the webpage now prompts users to manage their privacy settings by choosing between customizing their preferences or accepting all cookies, emphasizing the importance of privacy choices. This update likely pertains to the website's Cookie Preferences section, indicating a focus on privacy and data management for users visiting the site.
    Difference
    30%
    Check dated 2024-02-26T23:01:53.000Z thumbnail image
  5. Check
    4 days ago
    Change Detected
    Summary
    Important update:The recent change on the webpage regarding the value "Customize My Settings" now represents "Customize My Settings has recently changed to." This change may indicate an update or modification related to privacy settings or preferences on the website, possibly concerning user data management or consent options.
    Difference
    44%
    Check dated 2024-02-25T22:44:05.000Z thumbnail image
  6. Check
    6 days ago
    Change Detected
    Summary
    Important update:The recent change on the webpage indicates that the FDA has granted priority review to Merck's application for KEYTRUDA® (pembrolizumab) plus chemotherapy as a treatment for primary advanced or recurrent endometrial carcinoma. This update represents a significant development in the potential treatment options for patients with this type of cancer.
    Difference
    34%
    Check dated 2024-02-23T22:33:34.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.